Cardiovascular Diseases Clinical Trial
To determine whether the dietary intake of trans-fatty acids derived from partially hydrogenated unsaturated fatty acids measured through a biomarker are directly associated with the risk of primary cardiac arrest.
BACKGROUND:
The potential role of omega-3 PUFA intake in the prevention of coronary heart disease is
supported by studies among Greenland Eskimos, the Japanese, the Dutch, and data from the
Western Electric Study. The low incidence of coronary heart disease among Eskimos and
Japanese populations has been attributed to high dietary intake of fish oils. In addition, a
large cohort study from the Netherlands found an inverse relationship between regular fish
consumption and coronary heart disease mortality. Mortality from coronary heart disease was
increased 2.5 fold among persons who did not consume fish compared to those who consumed at
least 30 grams/day or the equivalent of 1-2 fish meals per week. There was no evidence that
increasing fish intake above 30 grams per day provided additional benefit; moderate intake
had the greatest effect on coronary heart disease mortality. Dietary omega-3 PUFA intake,
though modest, was also inversely related to coronary heart disease mortality. Analysis of
dietary data from the Western Electric Study cohort also suggested an inverse relation
between fish consumption and coronary heart disease mortality. In contrast, cohort studies
from Hawaii and Norway observed no relation between fish consumption and coronary heart
disease. However, fish consumption was higher in these populations and there were few
individuals who did not consume fish. Prior to the present study, there had been no studies
of the relation between dietary fish intake and the risk of primary cardiac arrest.
DESIGN NARRATIVE:
The study has a case-control design. Beginning in July 1990, through Emergency Medical
Service incident reports, all cases of primary cardiac arrest, ages 25-74, without prior
clinical heart diseases, were identified in Seattle and suburban King County, Washington
during the period April 1990 to March 1994. Controls were identified from the same community
using random digit dialing. Blood specimens from cases and controls were analyzed to
determine red-cell membrane fatty acid composition. Spouses of cases and controls were
interviewed to assess dietary intake of long-chain omega-3 PUFAs (a function of the amount
of seafood consumed), usual fat consumption, changes in dietary intake, and presence or
absence of other risk factors for primary cardiac arrest. Analyses were conducted to assess
the relation between dietary intake and red-cell membrane omega-3-fatty acid levels and to
assess whether there was a threshold or dose response effect for each fatty acid.
The study was renewed in 1996 through June, 2000. During the initial funding period studies
were conducted on the relationship to primary cardiac arrest of dietary intake of long chain
n-3 polyunsaturated fatty acids from seafood. The investigators are now extending the
population-based, case-control study to determine whether the dietary intake of trans-fatty
acids derived from partially hydrogenated unsaturated fatty acids measured through a
biomarker are directly associated with the risk of primary cardiac arrest. Cases of PCA who
were attended by paramedics in King County, Washington are identified. Demographically
similar controls are identified from the same community using random digit dialing. Blood
specimens from both previously identified and newly identified cases (collected by
paramedics in the field) and controls are analyzed for red cell membrane total trans-fatty
acid levels. This serves as a biomarker of dietary trans-fatty acid intake.
Spouses of subjects are interviewed to obtain information on usual saturated fat intake,
recent changes in diet and other risk factors. Additionally, among spouses of newly
identified subjects, the types of fat used in cooking and as spreads are assessed. Analyses
focus on the relationship between red cell membrane total trans-fatty acid levels and the
risk of PCA after adjusting for saturated fat intake and other risk factors.
The investigators also plan to extend a detailed diet substudy in a subset of control
subjects to confirm the relationship between the dietary intake of trans-fatty acids and red
cell membrane levels and evaluate whether the relationship is independent of other
nutrients.
The study has been renewed through March 2006.
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|